Peter P. Pfreundschuh - Net Worth and Insider Trading
Peter P. Pfreundschuh Net Worth
The estimated net worth of Peter P. Pfreundschuh is at least $2 Million dollars as of 2024-05-01. Peter P. Pfreundschuh is the CFO of Voyager Therapeutics Inc and owns about 175,669 shares of Voyager Therapeutics Inc (VYGR) stock worth over $1 Million. Peter P. Pfreundschuh is the CFO of UroGen Pharma Ltd and owns about 10,405 shares of UroGen Pharma Ltd (URGN) stock worth over $143,797. Peter P. Pfreundschuh is also the CFO of Frequency Therapeutics Inc and owns about 8,927 shares of Frequency Therapeutics Inc (FREQ) stock worth over $2,675. Details can be seen in Peter P. Pfreundschuh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter P. Pfreundschuh has not made any transactions after 2024-02-21 and currently still holds the listed stock(s).
Transaction Summary of Peter P. Pfreundschuh
Peter P. Pfreundschuh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter P. Pfreundschuh owns 6 companies in total, including UroGen Pharma Ltd (URGN) , Sucampo Pharmaceuticals Inc (SCMP) , and Immunomedics Inc (IMMU) among others .
Click here to see the complete history of Peter P. Pfreundschuh’s form 4 insider trades.
Insider Ownership Summary of Peter P. Pfreundschuh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2020-10-15 | CFO |
| SCMP | Sucampo Pharmaceuticals Inc | 2018-02-13 | CFO |
| IMMU | Immunomedics Inc | 2015-08-20 | Chief Financial Officer |
| FREQ | Frequency Therapeutics Inc | 2022-02-22 | Chief Financial Officer |
| VYGR | Voyager Therapeutics Inc | 2024-02-21 | Chief Financial Officer |
| KRRO | Korro Bio Inc | 2020-12-01 | Chief Financial Officer |
Peter P. Pfreundschuh Latest Holdings Summary
Peter P. Pfreundschuh currently owns a total of 3 stocks. Among these stocks, Peter P. Pfreundschuh owns 175,669 shares of Voyager Therapeutics Inc (VYGR) as of February 21, 2024, with a value of $1 Million and a weighting of 90.34%. Peter P. Pfreundschuh owns 10,405 shares of UroGen Pharma Ltd (URGN) as of October 15, 2020, with a value of $143,797 and a weighting of 9.48%. Peter P. Pfreundschuh also owns 8,927 shares of Frequency Therapeutics Inc (FREQ) as of February 22, 2022, with a value of $2,675 and a weighting of 0.18%.
Latest Holdings of Peter P. Pfreundschuh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics Inc | 2024-02-21 | 175,669 | 7.80 | 1,370,218 |
| URGN | UroGen Pharma Ltd | 2020-10-15 | 10,405 | 13.82 | 143,797 |
| FREQ | Frequency Therapeutics Inc | 2022-02-22 | 8,927 | 0.30 | 2,675 |
Holding Weightings of Peter P. Pfreundschuh
Peter P. Pfreundschuh Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter P. Pfreundschuh has made a total of 2 transactions in Voyager Therapeutics Inc (VYGR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Voyager Therapeutics Inc is the sale of 3,764 shares on February 21, 2024, which brought Peter P. Pfreundschuh around $28,079.
According to the SEC Form 4 filings, Peter P. Pfreundschuh has made a total of 9 transactions in UroGen Pharma Ltd (URGN) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in UroGen Pharma Ltd is the sale of 2,400 shares on October 15, 2020, which brought Peter P. Pfreundschuh around $52,248.
According to the SEC Form 4 filings, Peter P. Pfreundschuh has made a total of 3 transactions in Frequency Therapeutics Inc (FREQ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Frequency Therapeutics Inc is the sale of 2,946 shares on February 22, 2022, which brought Peter P. Pfreundschuh around $10,871.
Insider Trading History of Peter P. Pfreundschuh
- 1
Peter P. Pfreundschuh Trading Performance
Peter P. Pfreundschuh Ownership Network
Ownership Network List of Peter P. Pfreundschuh
Ownership Network Relation of Peter P. Pfreundschuh
Peter P. Pfreundschuh Owned Company Details
What does UroGen Pharma Ltd do?
Who are the key executives at UroGen Pharma Ltd?
Peter P. Pfreundschuh is the CFO of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include Chief Medical Officer Mark Schoenberg , General Counsel Jason Drew Smith , and Chief Financial Officer Dong Kim .
UroGen Pharma Ltd (URGN) Insider Trades Summary
Over the past 18 months, Peter P. Pfreundschuh made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 21,478 shares made by Mark Schoenberg , and a net sale of 15,422 shares made by Jason Drew Smith .
In summary, during the past 3 months, insiders sold 12,000 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 12,000 shares. During the past 18 months, 36,900 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 36,900 shares.
UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
UroGen Pharma Ltd Insider Transactions
Peter P. Pfreundschuh Mailing Address
Above is the net worth, insider trading, and ownership report for Peter P. Pfreundschuh. You might contact Peter P. Pfreundschuh via mailing address: C/o Immunomedics, Inc., 300 The American Road, Morris Plains Nj 07950.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
